Macrophage phenotypes during tissue repair

Journal of Leukocyte Biology

Volumn 93, Issue 6, 2013, Pages 875-881

  Novak, Margaret L ^a   Koh, Timothy J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cell therapy; Fibrosis; Inflammation; M2a; Regeneration; Wound healing

Indexed keywords

CELL ACTIVATION; CELL POPULATION; FIBROSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; TISSUE REPAIR; WOUND HEALING;

CELL THERAPY; FIBROSIS; INFLAMMATION; M2A; REGENERATION; WOUND HEALING;

ANIMALS; HUMANS; MACROPHAGES; PHENOTYPE; REGENERATION; WOUND HEALING;

EID: 84878419732     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1012512     Document Type: Review

References (80)

1. Lucas, T., Waisman, A., Ranjan, R., Roes, J., Krieg, T., Müller, W., Roers, A., Eming, S. A. (2010) Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 184, 3964-3977.
2. Mirza, R., DiPietro, L. A., Koh, T. J. (2009) Selective and specific macrophage ablation is detrimental to wound healing in mice. Am. J. Pathol. 175, 2454-2462.
3. Summan, M., Warren, G. L., Mercer, R. R., Chapman, R., Hulderman, T., Van Rooijen, N., Simeonova, P. P. (2006) Macrophages and skeletal muscle regeneration: a clodronate-containing liposome depletion study. Am. J. Physiol. 290, R1488-R1495.
4. Van Amerongen, M. J., Harmsen, M. C., van Rooijen, N., Petersen, A. H., van Luyn, M. J. (2007) Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am. J. Pathol. 170, 818-829.
5. Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., Iredale, J. P. (2005) Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56-65.
6. Moreira, A. P., Hogaboam, C. M. (2011) Macrophages in allergic asthma: fine-tuning their pro- and anti-inflammatory actions for disease resolution. J. Interferon Cytokine Res. 31, 485-491.
7. Moyer, A. L., Wagner, K. R. (2011) Regeneration versus fibrosis in skeletal muscle. Curr. Opin. Rheumatol. 23, 568-573.
8. Murray, P. J., Wynn, T. A. (2011) Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737.
9. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
10. Heymann, F., Trautwein, C., Tacke, F. (2009) Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm. Allergy Drug Targets 8, 307-318.
11. Ricardo, S. D., van Goor, H., Eddy, A. A. (2008) Macrophage diversity in renal injury and repair. J. Clin. Invest. 118, 3522-3530.
12. Nathan, C. (1991) Mechanisms and modulation of macrophage activation. Behring Inst. Mitt. Feb, 200-207.
13. Stein, M., Keshav, S., Harris, N., Gordon, S. (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292.
14. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
15. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
16. Louis, C. A., Mody, V., Henry, W. L., Reichner, J. S., Albina, J. E. (1999) Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages. Am. J. Physiol. 276, R237-R242.
17. Song, E., Ouyang, N., Hörbelt, M., Antus, B., Wang, M., Exton, M. S. (2000) Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 204, 19-28.
18. Anderson, C. F., Gerber, J. S., Mosser, D. M. (2002) Modulating macrophage function with IgG immune complexes. J. Endotoxin Res. 8, 477-481.
19. Stout, R. D., Jiang, C., Matta, B., Tietzel, I., Watkins, S. K., Suttles, J. (2005) Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175, 342-349.
20. Buechler, C., Ritter, M., Orsó, E., Langmann, T., Klucken, J., Schmitz, G. (2000) Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J. Leukoc. Biol. 67, 97-103.
21. Ambarus, C. A., Krausz, S., van Eijk, M., Hamann, J., Radstake, T. R., Reedquist, K. A., Tak, P. P., Baeten, D. L. (2012) Systematic validation of specific phenotypic markers for in vitro polarized human macrophages. J. Immunol. Methods 375, 196-206.
22. Ren, Y., Savill, J. (1998) Apoptosis: the importance of being eaten. Cell Death Differ. 5, 563-568.
23. Fadok, V. A., McDonald, P. P., Bratton, D. L., Henson, P. M. (1998) Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem. Soc. Trans. 26, 653-656.
24. Bréchot, N., Gomez, E., Bignon, M., Khallou-Laschet, J., Dussiot, M., Cazes, A., Alanio-Bréchot, C., Durand, M., Philippe, J., Silvestre, J. S., Van Rooijen N., Corvol, P., Nicoletti, A., Chazaud, B., Germain, S. (2008) Modulation of macrophage activation state protects tissue from necrosis during critical limb ischemia in thrombospondin-1-deficient mice. PLoS One 3, e3950.
25. Menzies, F. M., Henriquez, F. L., Alexander, J., Roberts, C. W. (2010) Sequential expression of macrophage anti-microbial/inflammatory and wound healing markers following innate, alternative and classical activation. Clin. Exp. Immunol. 160, 369-379.
26. Hart, P. H., Jones, C. A., Finlay-Jones, J. J. (1995) Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their responses to IL-4 and IL-10. J. Leukoc. Biol. 57, 909-918.
27. Heusinkveld, M., de Vos van Steenwijk, P. J., Goedemans, R., Ramwadhdoebe, T. H., Gorter, A., Welters, M. J., van Hall, T., van der Burg, S. H. (2011) M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells. J. Immunol. 187, 1157-1165.
28. Murray, P. J., Wynn, T. A. (2011) Obstacles and opportunities for understanding macrophage polarization. J. Leukoc. Biol. 89, 557-563.
29. Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., Locati, M. (2013) Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 229, 176-185.
30. Mosser, D. M. (2003) The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212.
31. Vidal, B., Serrano, A. L., Tjwa, M., Suelves, M., Ardite, E., De Mori, R., Baeza-Raja, B., Martínez de Lagrán, M., Lafuste, P., Ruiz-Bonilla, V., Jardí, M., Gherardi, R., Christov, C., Dierssen, M., Carmeliet, P., Degen, J. L., Dewerchin, M., Muñoz-Cánoves, P. (2008) Fibrinogen drives dystrophic muscle fibrosis via a TGFβ/alternative macrophage activation pathway. Genes Dev. 22, 1747-1752.
32. Foster, W., Li, Y., Usas, A., Somogyi, G., Huard, J. (2003) γ Interferon as an antifibrosis agent in skeletal muscle. J. Orthop. Res. 21, 798-804.
33. Daley, J. M., Brancato, S. K., Thomay, A. A., Reichner, J. S., Albina, J. E. (2010) The phenotype of murine wound macrophages. J. Leukoc. Biol. 87, 59-67.
34. Brancato, S. K., Albina, J. E. (2011) Wound macrophages as key regulators of repair: origin, phenotype, and function. Am. J. Pathol. 178, 19-25.
35. Shearer, J. D., Richards, J. R., Mills, C. D., Caldwell, M. D. (1997) Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am. J. Physiol. 272, E181-E190.
36. Munder, M., Mollinedo, F., Calafat, J., Canchado, J., Gil-Lamaignere, C., Fuentes, J. M., Luckner, C., Doschko, G., Soler, G., Eichmann, K., Müller, F. M., Ho, A. D., Goerner, M., Modolell, M. (2005) Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity. Blood 105, 2549-2556.
37. Raes, G., Brys, L., Dahal, B. K., Brandt, J., Grooten, J., Brombacher, F., Vanham, G., Noël, W., Bogaert, P., Boonefaes, T., Kindt, A., Van den Bergh, R., Leenen, P. J., De Baetselier, P., Ghassabeh, G. H. (2005) Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J. Leukoc. Biol. 77, 321-327.
38. Satriano, J., Matsufuji, S., Murakami, Y., Lortie, M. J., Schwartz, D., Kelly, C. J., Hayashi, S., Blantz, R. C. (1998) Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels. J. Biol. Chem. 273, 15313-15316.
39. Wynn, T. A., Barron, L. (2010) Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 30, 245-257.
40. Wehling-Henricks, M., Jordan, M. C., Gotoh, T., Grody, W. W., Roos, K. P., Tidball, J. G. (2010) Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy. PLoS One 5, e10763.
41. Villalta, S. A., Nguyen, H. X., Deng, B., Gotoh, T., Tidball, J. G. (2009) Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum. Mol. Genet. 18, 482-496.
42. Hesse, M., Modolell, M., La Flamme, A. C., Schito, M., Fuentes, J. M., Cheever, A. W., Pearce, E. J., Wynn, T. A. (2001) Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 167, 6533-6544.
43. Jansen, A., Lewis, S., Cattell, V., Cook, H. T. (1992) Arginase is a major pathway of L-arginine metabolism in nephritic glomeruli. Kidney Int. 42, 1107-1112.
44. Jude, E. B., Boulton, A. J., Ferguson, M. W., Appleton, I. (1999) The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth factor β 1. Diabetologia 42, 748-757.
45. Schnoor, M., Cullen, P., Lorkowski, J., Stolle, K., Robenek, H., Troyer, D., Rauterberg, J., Lorkowski, S. (2008) Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J. Immunol. 180, 5707-5719.
46. Gratchev, A., Guillot, P., Hakiy, N., Politz, O., Orfanos, C. E., Schledzewski, K., Goerdt, S. (2001) Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein βIG-H3. Scand. J. Immunol. 53, 386-392.
47. Kim, H. J., Kim, I. S. (2008) Transforming growth factor-β-induced gene product, as a novel ligand of integrin αMβ2, promotes monocytes adhesion, migration and chemotaxis. Int. J. Biochem. Cell Biol. 40, 991-1004.
48. Bae, J. S., Lee, S. H., Kim, J. E., Choi, J. Y., Park, R. W., Yong Park, J., Park, H. S., Sohn, Y. S., Lee, D. S., Bae Lee, E., Kim, I. S. (2002) βIg-H3 supports keratinocyte adhesion, migration, and proliferation through α3β1 integrin. Biochem. Biophys. Res. Commun. 294, 940-948.
49. LeBaron, R. G., Bezverkov, K. I., Zimber, M. P., Pavelec, R., Skonier, J., Purchio, A. F. (1995) β IG-H3, a novel secretory protein inducible by transforming growth factor-β, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro. J. Invest. Dermatol. 104, 844-849.
50. Nacu, N., Luzina, I. G., Highsmith, K., Lockatell, V., Pochetuhen, K., Cooper, Z. A., Gillmeister, M. P., Todd, N. W., Atamas, S. P. (2008) Macrophages produce TGF-β-induced (β-Ig-H3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts. J. Immunol. 180, 5036-5044.
51. Thapa, N., Lee, B. H., Kim, I. S. (2007) TGFBIp/β-Ig-H3 protein: a versatile matrix molecule induced by TGF-β. Int. J. Biochem. Cell Biol. 39, 2183-2194.
52. Yun, S. J., Kim, M. O., Kim, S. O., Park, J., Kwon, Y. K., Kim, I. S., Lee, E. H. (2002) Induction of TGF-β-inducible gene-h3 (βIg-H3) by TGF-β1 in astrocytes: implications for astrocyte response to brain injury. Brain Res. Mol. Brain Res. 107, 57-64.
53. Bellón, T., Martínez, V., Lucendo, B., del Peso, G., Castro, M. J., Aroeira, L. S., Rodríguez-Sanz, A., Ossorio, M., Sánchez-Villanueva, R., Selgas, R., Bajo, M. A. (2011) Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis. Nephrol. Dial. Transplant. 26, 2995-3005.
54. Mahdavian Delavary, B., van der Veer, W. M., van Egmond, M., Niessen, F. B., Beelen, R. H. (2011) Macrophages in skin injury and repair. Immunobiology 216, 753-762.
55. Schäffer, M., Bongartz, M., Hoffmann, W., Viebahn, R. (2006) Regulation of nitric oxide synthesis in wounds by IFN-β depends on TNF-β. J. Invest. Surg. 19, 371-379.
56. Miao, M., Niu, Y., Xie, T., Yuan, B., Qing, C., Lu, S. (2012) Diabetesimpaired wound healing and altered macrophage activation: a possible pathophysiologic correlation. Wound Repair Regen. 20, 203-213.
57. Cheng, M., Nguyen, M. H., Fantuzzi, G., Koh, T. J. (2008) Endogenous interferon-γ is required for efficient skeletal muscle regeneration. Am. J. Physiol. Cell. Physiol. 294, C1183-C1191.
58. Takamiya, M., Fujita, S., Saigusa, K., Aoki, Y. (2008) Simultaneous detection of eight cytokines in human dermal wounds with a multiplex bead-based immunoassay for wound age estimation. Int. J. Legal Med. 122, 143-148.
59. Villalta, S. A., Deng, B., Rinaldi, C., Wehling-Henricks, M., Tidball, J. G. (2011) IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation. J. Immunol. 187, 5419-5428.
60. Mirza, R., Koh, T. J. (2011) Dysregulation of monocyte/macrophage phenotype in wounds of diabetic mice. Cytokine 56, 256-264.
61. Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., Weiss, J. M., Wlaschek, M., Sunderkötter, C., Scharffetter-Kochanek, K. (2011) An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J. Clin. Invest. 121, 985-997.
62. Karlmark, K. R., Zimmermann, H. W., Roderburg, C., Gassler, N., Wasmuth, H. E., Luedde, T., Trautwein, C., Tacke, F. (2010) The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology 52, 1769-1782.
63. Lee, S., Huen, S., Nishio, H., Nishio, S., Lee, H. K., Choi, B. S., Ruhrberg, C., Cantley, L. G. (2011) Distinct macrophage phenotypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 22, 317-326.
64. Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., Chazaud, B. (2007) Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204, 1057-1069.
65. Perdiguero, E., Sousa-Victor, P., Ruiz-Bonilla, V., Jardí, M., Caelles, C., Serrano, A. L., Muñoz-Cánoves, P. (2011) p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair. J. Cell Biol. 195, 307-322.
66. Albina, J. E. (1995) On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukoc. Biol. 58, 643-649.
67. Mahoney, E., Reichner, J., Bostom, L. R., Mastrofrancesco, B., Henry, W., Albina, J. (2002) Bacterial colonization and the expression of inducible nitric oxide synthase in murine wounds. Am. J. Pathol. 161, 2143-2152.
68. Kawao, N., Nagai, N., Tamura, Y., Okada, K., Yano, M., Suzuki, Y., Umemura, K., Ueshima, S., Matsuo, O. (2011) Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice. Thromb. Haemost. 105, 892-900.
69. Aoyama, T., Inokuchi, S., Brenner, D. A., Seki, E. (2010) CX3CL1- CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice. Hepatology 52, 1390-1400.
70. Loke, P., Gallagher, I., Nair, M. G., Zang, X., Brombacher, F., Mohrs, M., Allison, J. P., Allen, J. E. (2007) Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection. J. Immunol. 179, 3926-3936.
71. Bryan, D., Walker, K. B., Ferguson, M., Thorpe, R. (2005) Cytokine gene expression in a murine wound healing model. Cytokine 31, 429-438.
72. Fraccarollo, D., Galuppo, P., Schraut, S., Kneitz, S., van Rooijen, N., Ertl, G., Bauersachs, J. (2008) Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension 51, 905-914.
73. Deng, B., Wehling-Henricks, M., Villalta, S. A., Wang, Y., Tidball, J. G. (2012) IL-10 triggers changes in macrophage phenotype that promote muscle growth and regeneration. J. Immunol. 189, 3669-3680.
74. Toschi, A., Severi, A., Coletti, D., Catizone, A., Musarò, A., Molinaro, M., Nervi, C., Adamo, S., Scicchitano, B. M. (2011) Skeletal muscle regeneration in mice is stimulated by local overexpression of V1a-vasopressin receptor. Mol. Endocrinol. 25, 1661-1673.
75. Yona, S., Jung, S. (2010) Monocytes: subsets, origins, fates and functions. Curr. Opin. Hematol. 17, 53-59.
76. Nair, M. G., Gallagher, I. J., Taylor, M. D., Loke, P., Coulson, P. S., Wilson, R. A., Maizels, R. M., Allen, J. E. (2005) Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect. Immun. 73, 385-394.
77. Harbord, M., Novelli, M., Canas, B., Power, D., Davis, C., Godovac-Zimmermann, J., Roes, J., Segal, A. W. (2002) Ym1 is a neutrophil granule protein that crystallizes in p47phox-deficient mice. J. Biol. Chem. 277, 5468-5475.
78. Spencer, M., Yao-Borengasser, A., Unal, R., Rasouli, N., Gurley, C. M., Zhu, B., Peterson, C. A., Kern, P. A. (2010) Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am. J. Physiol. Endocrinol. Metab. 299, E1016-E1027.
79. Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J. L., Libby, P., Weissleder, R., Pittet, M. J. (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037-3047.
80. Raes, G., Van den Bergh, R., De Baetselier, P., Ghassabeh, G. H., Scotton, C., Locati, M., Mantovani, A., Sozzani, S. (2005) Arginase-1 and Ym1 are markers for murine, but not human, alternatively activated myeloid cells. J. Immunol. 174, 6561-6562.